PMID- 38054640 OWN - NLM STAT- MEDLINE DCOM- 20240112 LR - 20240112 IS - 1479-6813 (Electronic) IS - 0952-5041 (Linking) VI - 72 IP - 2 DP - 2024 Feb 1 TI - Oxidative and ER stress by elevated insulin biosynthesis and palmitic acid in insulin-producing cells. LID - e230087 [pii] LID - 10.1530/JME-23-0087 [doi] AB - The early phase of type 2 diabetes mellitus (T2DM) is characterised by insulin resistance, which can initially be compensated by elevated insulin secretion. However, as postulated by the workload hypothesis, over time harming insulin requirements contribute to beta-cell dysfunction and death. The mechanisms behind this transition are complex and not fully understood but involve factors such as endoplasmic reticulum (ER) stress raised by gluco/lipotoxicity. To investigate the effect of excessive insulin folding on ER luminal H2O2 generation, ER stress and viability, insulin was expressed glucose-independently by a doxycycline-regulated Tet-On system in insulin-producing RINm5F cells. Additionally, the effect of palmitic acid (PA) as a subsidiary T2DM-associated factor was examined in this model system. Elevated insulin expression increased ER luminal H2O2 concentration quantified by the fluorescent sensor protein TriPer and reduced viability, but did not activate apoptosis. However, when combined with PA, insulin expression resulted in a significant increase in ER stress and apoptosis. Expression of ER-localised catalase verified the specificity of the applied H2O2 detection method without attenuating ER stress, caspase activation or viability loss. These findings suggest that hyperinsulinism alone can cause increased ER luminal H2O2 generation, mild ER stress and reduced viability, while hyperinsulinism in combination with PA accelerates these processes and triggers apoptosis. The inability of ER catalase to counteract these effects suggests that further damaging factors besides H2O2 are involved in cell dysfunction. Finally, reducing the high insulin demand in the initial phase of T2DM may be crucial in preventing further beta-cell damage caused by gluco/lipotoxicity. FAU - Vidrio-Huerta, Brenda AU - Vidrio-Huerta B AD - Institute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany. FAU - Plotz, Thomas AU - Plotz T AD - Institute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany. FAU - Lortz, Stephan AU - Lortz S AUID- ORCID: 0000-0002-3392-8978 AD - Institute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany. LA - eng PT - Journal Article DEP - 20240111 PL - England TA - J Mol Endocrinol JT - Journal of molecular endocrinology JID - 8902617 RN - 2V16EO95H1 (Palmitic Acid) RN - EC 1.11.1.6 (Catalase) RN - BBX060AN9V (Hydrogen Peroxide) RN - 0 (Insulin) SB - IM MH - Humans MH - Palmitic Acid/pharmacology MH - Catalase/metabolism/pharmacology MH - *Diabetes Mellitus, Type 2/metabolism MH - Hydrogen Peroxide/pharmacology MH - *Insulin-Secreting Cells/metabolism MH - Insulin/metabolism MH - Apoptosis MH - *Insulin Resistance MH - Oxidative Stress MH - Endoplasmic Reticulum Stress OTO - NOTNLM OT - catalase OT - endoplasmic reticulum OT - gluco-lipotoxicity OT - insulin-secreting cells OT - palmitic acid OT - protein folding OT - reactive oxygen species EDAT- 2023/12/06 12:43 MHDA- 2024/01/12 06:43 CRDT- 2023/12/06 08:42 PHST- 2023/11/02 00:00 [received] PHST- 2023/12/06 00:00 [accepted] PHST- 2024/01/12 06:43 [medline] PHST- 2023/12/06 12:43 [pubmed] PHST- 2023/12/06 08:42 [entrez] AID - JME-23-0087 [pii] AID - 10.1530/JME-23-0087 [doi] PST - epublish SO - J Mol Endocrinol. 2024 Jan 11;72(2):e230087. doi: 10.1530/JME-23-0087. Print 2024 Feb 1.